Authors
Loading...
Review reveals therapeutic targeting strategies for microRNAs in tumor models, highlighting their utility as oncogenic drivers and clinical targets.
Ji et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: